GRAS Notices
-
GRN No. 860
Algal oil (36% docosahexaenoic acid) from Schizochytrium sp. strain DHF
Intended Use: | Ingredient in the same food categories as those currently listed in 21 CFR 184.1472(a)(3) (Menhaden oil), at use levels of algal oil (≥36% DHA) that are no more than 27.775% of the levels specified for menhaden oil in that regulation. Hubei Fuxing also intends to use algal oil (≥36% DHA) as an ingredient in exempt and non-exempt, soy-, whey-, cows milk-, amino acid-, and hydrolyzed protein-based infant formula for pre-term and term infants at a maximum level of 0.5% of total fat as DHA in combination with a safe and suitable source of arachidonic acid (ARA) at a ratio ranging from 1:1 to 1:2 of DHA to ARA. |
---|---|
Basis: | Scientific procedures |
Notifier: | Hubei Fuxing BioTechnology |
Notifier Address: | Floor 11th, Bldg.23, Yinhu Enterprise Zone, Baishazhou Ave. Hongshan District, Hubei Province China |
GRAS Notice (releasable information): | GRN 860 (in PDF) (8.6 MB) |
Date of closure: | Sep 3, 2019 |
FDA's Letter: | At the notifier's request, FDA ceased to evaluate this notice (in PDF) (59 kB) |
-